Todd FoleyTodd Foley is a Managing Director at MPM and a General Partner managing the MPM-Novartis BioVentures IV Strategic Fund. Prior to joining MPM in 1999, Todd Foley worked in Business Development at Genentech and management consulting with Arthur D. Little. He holds a B.S. in Chemistry from MIT, and an M.B.A. from Harvard Business School where he was co-president of the Healthcare & Biotechnology Club. At MPM, he has been actively involved in over 15 investments including a part-time engagement as COO for Centagenetix during its start-up phase and VP of Business Development for AVEO Pharmaceuticals. He is a member of the Board of Directors of NeuroMed Pharmaceuticals and Chiasma Inc.; a past board member of Primera Biosystems, Alinea Pharmaceuticals, BioValve Technologies (now Valeritas), Centagenetix (now Elixir), Coelacanth (now Lexicon Genetics), and Intracel. |
|
